A study suggests that an experimental drug may modestly extend the lives of men with advanced prostate cancer who are no longer responding to other treatments.
The drug, cabazitaxel (kuh-BAH-zuh-TAX-uhl), helped men live an average of 10 weeks longer in a large study sponsored by the drug's maker, Sanofi-Aventis. Researchers hope the drug can make more of a difference in men who aren't so sick. The federal Food and Drug Administration has said it will give the drug fast review.
A new line of caffeinated chewing gum is causing jitters among health advocates and prompting federal officials to take a new look at the proliferation of jolt-infused foods, including those marketed to children and teens.
Stress, the slowing of metabolism of middle age, and hormone changes after having a baby are three main reasons why many people see the numbers on the scale going up. Dr. Mehmet Oz shares tips on how to shed those final 10 pounds.